Tesla teases a new Model Y L variant is 'coming soon' in a video posted to Chinese social media — Positive
TSLA Business Insider — August 18, 2025Tesla posted a new video on Chinese social media showing off the Model Y L, a longer wheelbase variant of the popular vehicle. Translated from Chinese, the post said that the Model Y L is "coming soon.

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced it will participate in upcoming conferences. Jeff Niew, President and CEO of Knowles will participate in The Jefferies Industrial Conference in New York City on September 3, 2025. Contact your Jefferies representative to schedul.

Consolidation Among Automakers Is Increasingly Likely: The Stellantis 'Bull' Case — Negative
STLA Seeking Alpha — August 18, 2025European carmakers face a perfect storm: stagnant sales, fierce Chinese competition, lagging EV tech, and barriers to export to U.S. and China. The industry is in need of consolidation. Stellantis N.V. continues to struggle with declining shipments, negative FCF, and U.S. tariff exposure under new CEO Antonio Filosa, despite guiding for a 2026 turnaround. However, I think Stellantis could benefit from industry consolidation due to its shareholder base, cash reserves, and potential to spin off or sell its vast portfolio of brands.

Okta Plunges 27% in 3 Months: Buy, Sell or Hold the Stock? — Negative
OKTA Zacks Investment Research — August 18, 2025OKTA's shares slump amid federal business slowdown and macro headwinds, but its expanding portfolio and partner base signal long-term strength.

Novo Nordisk to sell weight-loss drug for $499 to eligible customers — Positive
NVO Fox Business — August 18, 2025Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims — Positive
GDRX HIMS NVO Fast Company — August 18, 2025Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the lowest-ever out-of-pocket prices for Ozempic and Wegovy.

Kenvue's fundamental performance looks disastrous, with revenue and margins going in the wrong direction. In that context, a 20x-plus multiple to 2025 adjusted EPS looks far too high. But a new board, new leadership, and new strategy suggest real change is on the way for a business where execution clearly is a concern.

Newsmax settles Dominion defamation case for $67 million, says it couldn't get fair trial — Negative
NMAX Reuters — August 18, 2025Newsmax Media has agreed to pay $67 million to Dominion Voting Systems to settle a $1.6 billion defamation lawsuit over false claims that the voting machine company rigged the 2020 election against U.S. President Donald Trump, it said on Monday.

Can ServiceNow's Expanding AI-Powered Platform Drive the Stock Higher? — Neutral
NOW Zacks Investment Research — August 18, 2025NOW grows AI-driven revenues with NVIDIA and Logik.ai support, but execution risks and valuation spark caution.

Is the Options Market Predicting a Spike in TKO Group Holdings Stock? — Neutral
TOWN Zacks Investment Research — August 18, 2025Investors need to pay close attention to TKO Group Holdings stock based on the movements in the options market lately.

Poland's economy is growing rapidly, supported by EU funds, nearshoring, and strong private consumption, making EPOL an attractive but risky investment. EPOL offers concentrated exposure to Poland's financial sector and key industries, but high concentration increases company-specific and sector risks. Despite strong recent performance and lower valuations than Europe, the price surge suggests a potential bubble, warranting caution before buying.

Soligenix, Inc. SNGX stock is higher on Monday after the U.S. Food and Drug Administration granted orphan drug designation to dusquetide, the active ingredient in SGX945, for Behçet's Disease.

Sunrun Poised To Gain Market Share As Policy Shifts Boost Its Solar Model: Analyst — Positive
RUN Benzinga — August 18, 2025RBC Capital's Christopher Dendrinos upgraded Sunrun RUN to Outperform with a $16 price target. There is clearer long-term growth visibility after the recent U.S. Treasury guidance eased regulatory uncertainty, he explained.

What Makes Standard Motor Products (SMP) a Strong Momentum Stock: Buy Now? — Positive
SMP Zacks Investment Research — August 18, 2025Does Standard Motor Products (SMP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why LATAM (LTM) is a Great Momentum Stock to Buy — Positive
LTM Zacks Investment Research — August 18, 2025Does LATAM (LTM) have what it takes to be a top stock pick for momentum investors? Let's find out.

All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy — Positive
CAH Zacks Investment Research — August 18, 2025Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

United Fire Group (UFCS) is a Great Momentum Stock: Should You Buy? — Positive
UFCS Zacks Investment Research — August 18, 2025Does United Fire Group (UFCS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Hyperfine (HYPR) Upgraded to Buy: Here's Why — Positive
HYPR Zacks Investment Research — August 18, 2025Hyperfine (HYPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Phinia (PHIN) is a Great Momentum Stock: Should You Buy? — Positive
PHIN Zacks Investment Research — August 18, 2025Does Phinia (PHIN) have what it takes to be a top stock pick for momentum investors? Let's find out.

EMX Royalty Corp. (EMX) is a Great Momentum Stock: Should You Buy? — Positive
EMX Zacks Investment Research — August 18, 2025Does EMX Royalty Corp. (EMX) have what it takes to be a top stock pick for momentum investors? Let's find out.
